The integration of automation into routine laboratory tasks is becoming increasingly essential in the rapidly evolving scientific landscape.
INTEGRA Biosciences is committed to addressing these changing requirements of its customers. This is why the WELLJET reagent dispenser now supports API commands based on Standards in Laboratory Automation (SiLA-2) – developed by the SiLA Consortium – an open-source communication protocol for laboratory automation.
This new functionality simplifies the integration of the WELLJET into automated laboratory workflows, assisting laboratories in improving productivity and reproducibility. By reducing manual tasks, researchers can devote more time to complex problem-solving and innovation, making better use of their expertise and training.
Innovation through integration
Scientists continuously seek methods to automate repetitive and time-consuming liquid handling procedures to increase laboratory throughput while managing growing workloads. Automation also minimizes human errors, leading to more consistent and reliable results.
The newly introduced SiLA-2 standard allows seamless integration of laboratory instruments and systems from multiple manufacturers. This eliminates challenges commonly associated with proprietary systems – such as the need for complex, custom software development – while simultaneously promoting laboratory automation.
It also enhances the adaptability and scalability of automated systems by allowing devices to be added or replaced as required, ensuring long-term compatibility with emerging technologies and future advancements.
Image Credit: INTEGRA Biosciences
WELLJET and SiLA-2: The dynamic dispensing duo
The highly compact WELLJET is designed to dispense reagents into microplates ranging from 6 to 1,536 wells, accommodating high throughput workflows across various applications, including ELISAs and cell-based assays.
The system uses novel cassette technology to eliminate variations in dispensing volumes between channels, reducing the need for cassette recalibration and enhancing precision while lowering operational costs.
The incorporation of SiLA-2 functionality enables the WELLJET to be directly integrated into an extensive array of SiLA-2-based automated workflows, spanning fields from drug discovery to clinical diagnostics.
The incorporation of SiLA-2 protocol into the WELLJET’s control architecture reduces hands-on time and increases throughput, bringing more standardization to laboratory processes. This helps laboratories in meeting increasing demands for efficiency and reproducibility, while future-proofing operations with scalable and interconnected automation systems.
About INTEGRA Biosciences
INTEGRA provides innovative solutions for liquid handling and media preparation applications that serve the needs of its customers in research, diagnostics and quality control laboratories.
Its instruments and plastic consumables are developed and manufactured in Zizers, Switzerland, and Hudson, NH, USA. In order to remain close to its customers, the company maintains a direct sales and support organization in several North American, European and Asian countries, as well as a network of over 100 highly trained distribution partners worldwide.
In recent years, the company has focused on developing a new and technologically advanced range of lab devices that are simple to use and meet the ergonomic needs of its customers.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.